FAQ

4-hydroxy-3-methoxymethamphetamine

Known as: 3-methoxy-4-hydroxymethamphetamine, 4,3-HMM, HMMA cpd 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2017
051019882017

Related topics

Related topics

1 relation

Broader (1)

Methamphetamine

Related mentions per year

Related mentions per year

1939-2018
19401960198020002020
4-hydroxy-3-methoxymethamphetamine
Methamphetamine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Analytical interference of 4-hydroxy-3-methoxymethamphetamine with the measurement of plasma free normetanephrine by ultra-high pressure liquid chromatography-tandem mass spectrometry.
OBJECTIVES The diagnosis of pheochromocytoma relies on the measurement of plasma free metanephrines assay whose reliability has… (More)
  • figure 1
  • figure 2
Is this relevant?
2011
2011
Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4-dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human…
3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) is excreted in human urine mainly as conjugates of its metabolites 3,4… (More)
Is this relevant?
2011
2011
Investigation on the enantioselectivity of the sulfation of the methylenedioxymethamphetamine metabolites 3,4-dihydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine using the substrate…
Different pharmacokinetic properties are known for the two enantiomers of the entactogen 3,4-methylendioxy-methamphetamine (MDMA… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
2009
2009
4-Hydroxy-3-methoxymethamphetamine glucuronide as a phase II metabolite of 3,4-methylenedioxymethamphetamine: enzyme-assisted synthesis and involvement of human hepatic uridine 5'-diphosphate…
3,4-Methylenedioxymethamphetamine (MDMA), one of the most popular illicit recreational drugs, is metabolized primarily into 4… (More)
Is this relevant?
2008
2008
Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats.
The urinary concentrations of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA; Ecstasy), specifically 4-hydroxy-3… (More)
Is this relevant?
2008
2008
Conjugates of p-hydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine in blood obtained from methamphetamine and 3,4-methylenedioxymethamphetamine users: analysis by LC-MS-MS
A detailed procedure for simultaneous analysis of methamphetamine (MA), 3,4-methylenedioxymethamphetamine (MDMA) and their… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 2
  • table 3
Is this relevant?
2007
2007
Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine.
A sensitive and reliable LC-ESI-MS procedure for the simultaneous determination of MDMA and its five metabolites including 4… (More)
Is this relevant?
2007
2007
Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.
3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") is increasingly used by young people for its euphoric and empathic effects… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2007
2007
Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine…
3,4-Methylenedioxymethamphetamine (MDMA) is a recreational drug with neurotoxic potential. Pharmacokinetic data of MDMA and its… (More)
Is this relevant?
2002
2002
Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
A gas chromatography-mass spectrometry (GC-MS) method was used for the simultaneous quantitation of 3,4… (More)
  • table I
  • figure 1
  • figure 2
  • table II
  • figure 3
Is this relevant?